Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butylphthalide for mild subcortical ischemic vascular dementia
ChiCTR-IPR-17013143Phase 4Not yet recruiting
- Sponsor
- Tianjin Medical University General Hospital
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of butylphthalide in vascular dementia (2 arms), sponsored by Tianjin Medical University General Hospital. Primary endpoints: Auditory Verbal Learning Test, Brief Visuospatial Memory Test-Revised and 10 more. Planned start Aug 2017; status: not yet recruiting.
02
Drugs
butylphthalide
03
Conditions
vascular dementia
Beyond the preview
Go deeper on ChiCTR-IPR-17013143.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17013143.